Accelerating Innovation at Leica Biosystems slide image

Accelerating Innovation at Leica Biosystems

Reconciliation of GAAP to Adjusted P&L Metrics DANAHER CORPORATION Diluted Net Earnings Per Common Share from Continuing Operations (GAAP) 2 Amortization of acquisition-related intangible assets Acquisition-related items Impairments C B D E Fair value (gains) losses on investments Gain on disposition of certain product lines Tax effect of the above adjustments Discrete tax adjustments MCPS "as if converted" H Rounding F A Six-Month Period Ended Year-over- July 2, 2021 July 3, 2020 Year Change $ 4.57 $ 2.06 0.93 0.65 0.06 0.39 0.01 0.01 (0.27) 0.02 (0.02) (0.62) (0.15) (0.16) (0.04) 0.03 0.01 Adjusted Diluted Net Earnings Per Common Share from Continuing Operations (Non-GAAP) $ 4.98 $ 2.50 100 % 2 Each of the per share amounts above have been calculated assuming the Mandatory Convertible Preferred Stock ("MCPS") had been converted into shares of common stock. 3
View entire presentation